B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NFE2L2

MOLECULAR TARGET

NFE2 like bZIP transcription factor 2

UniProt: Q16236NCBI Gene: 4780202 compounds

NFE2L2 (NFE2 like bZIP transcription factor 2) is targeted by 202 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NFE2L2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Resveratrol2.7715
2Colchicine2.6413
3Vitamin2.5612
4Azacitidine2.5612
5Azacitidine2.5612
6Genistein2.4010
7Apigenin 5,7,4'-trihydroxy-flavone,2.309
8alpha-Linolenic Acid2.309
9Oxymetholone2.309
10Rotenone2.309
11Methylene Blue2.208
12Ethoxyquin Antioxidant; also2.208
13Nitrofurazone2.208
14Quercetin2.087
15Azathioprine2.087
16Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as2.087
17Mestranol2.087
18methoprene2.087
19Niclosamide2.087
20Phenelzine2.087
21vinblastine sulfate2.087
22chrysin1.956
23alyssin [Supplementary Concept]1.956
24Digitoxin1.956
25Digoxin1.956
26Flutamide1.956
27Hexachlorophene1.956
28Linoleic Acid1.956
29Vitamin K 31.956
30Nitrofurantoin1.956
31Ouabain1.956
32Podophyllotoxin1.956
33Thiabendazole 2-Substituted benzimidazole first introduced in 1962. It is active against1.956
34Toxaphene1.956
35DEAD-box RNA Helicases1.795
36Thioctic Acid1.795
37amlexanox1.795
38Bortezomib1.795
39Chlormadinone Acetate1.795
40Ethidium1.795
41Feprazone1.795
42Idazoxan1.795
43Leflunomide1.795
44Nocodazole Nocodazole is1.795
45Oxyphenbutazone1.795
46Thioctic Acid1.795
47Caffeine1.614
48propyl gallate1.614
49Ascorbic Acid1.614
50Methotrexate1.614

Showing top 50 of 202 compounds. Use the BiohacksAI search to explore all NFE2L2 modulators.

About NFE2L2 as a Drug Target

NFE2L2 (NFE2 like bZIP transcription factor 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 202 compounds with documented NFE2L2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NFE2L2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.